Correlation Between Sinphar Pharmaceutical and MPI

Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and MPI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and MPI into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sinphar Pharmaceutical Co and MPI Corporation, you can compare the effects of market volatilities on Sinphar Pharmaceutical and MPI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of MPI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and MPI.

Diversification Opportunities for Sinphar Pharmaceutical and MPI

-0.37

Correlation Coefficient

Sinphar Pharmaceutical  MPI

Very good diversification

The 3 months correlation between Sinphar and MPI is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and MPI Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MPI Corporation and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with MPI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MPI Corporation has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and MPI go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and MPI

Assuming the 90 days trading horizon Sinphar Pharmaceutical is expected to generate 5.26 times less return on investment than MPI. But when comparing it to its historical volatility, Sinphar Pharmaceutical Co is 3.39 times less risky than MPI. It trades about 0.04 of its potential returns per unit of risk. MPI Corporation is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  83,200  in MPI Corporation on October 7, 2024 and sell it today you would earn a total of  6,200  from holding MPI Corporation or generate 7.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sinphar Pharmaceutical Co  vs.  MPI Corp.

Sinphar Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Sinphar Pharmaceutical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

MPI Corporation

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in MPI Corporation are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, MPI showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sinphar Pharmaceutical and MPI

The main advantage of trading using opposite Sinphar Pharmaceutical and MPI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, MPI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MPI will offset losses from the drop in MPI's long position.

The idea behind Sinphar Pharmaceutical Co and MPI Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.